|
LOC653501 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.97459842815806E-14 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.68665081901054E-12 |
| Normal-vs-Stage2 |
7.15729999711812E-08 |
| Normal-vs-Stage3 |
6.55031584528842E-15 |
| Normal-vs-Stage4 |
<1E-12 |
| Stage1-vs-Stage2 |
1.077710E-02 |
| Stage1-vs-Stage3 |
1.981190E-01 |
| Stage1-vs-Stage4 |
1.041360E-04 |
| Stage2-vs-Stage3 |
2.318100E-03 |
| Stage2-vs-Stage4 |
1.75846999999063E-05 |
| Stage3-vs-Stage4 |
2.698500E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.63435931455069E-12 |
| Normal-vs-AfricanAmerican |
2.08719999950091E-07 |
| Normal-vs-Asian |
2.42827979946014E-12 |
| Caucasian-vs-AfricanAmerican |
3.671800E-01 |
| Caucasian-vs-Asian |
3.426600E-01 |
| AfricanAmerican-vs-Asian |
7.354600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.94209101525666E-13 |
| Normal-vs-Female |
1.64812608005604E-12 |
| Male-vs-Female |
3.260600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.63313806922361E-12 |
| Normal-vs-Age(41-60Yrs) |
1.68254299381942E-12 |
| Normal-vs-Age(61-80Yrs) |
1.82720505392808E-12 |
| Normal-vs-Age(81-100Yrs) |
3.819300E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.860200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.922300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.861400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.543000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.477600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.935200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.52920004121194E-09 |
| Classical-VS-Follicular |
1.753099999946E-06 |
| Classical-VS-Other |
6.740400E-01 |
| Classical-VS-Normal |
3.530509218308E-14 |
| Tall-VS-Follicular |
1.64079860809352E-12 |
| Tall-VS-Other |
2.501400E-01 |
| Tall-VS-Normal |
1.62436730732907E-12 |
| Follicular-VS-Other |
6.356200E-02 |
| Follicular-VS-Normal |
7.37140004591907E-09 |
| Other-VS-Normal |
1.830440E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.79518638737864E-12 |
| Normal-vs-N1 |
<1E-12 |
| N0-vs-N1 |
6.95990000076918E-08 |
|
|
